Validation of predicted mRNA splicing mutations using high-throughput transcriptome data

F1000Research

Volumn 3, Issue , 2014, Pages

  Viner, Coby ^a   Dorman, Stephanie N ^a   Shirley, Ben C ^b   Rogan, Peter K ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Cytognomix Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ARTICLE; AUTOMATION; COMPUTER MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; DNA SEQUENCE; EXOME; EXON SKIPPING; GENE MUTATION; GENETIC VARIABILITY; GENOME; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; INTRON; NUCLEOTIDE SEQUENCE; PREDICTION; RNA SEQUENCE; RNA SPLICING; STATISTICAL ANALYSIS; VALIDATION STUDY;

EID: 84979844527     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.3-8.v2     Document Type: Article

References (44)

1. Rogan PK Zou GY: Best practices for evaluating mutation prediction methods. Hum Mutat. 2013;34(11):1581-1582. 23955774 10.1002/humu.22401
2. Krawczak M Reiss J Cooper DN: The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum Genet. 1992;90(1-2):41-54. 1427786 10.1007/BF00210743
3. Rogan PK Faux BM Schneider TD: Information analysis of human splice site mutations. Hum Mutat. 1998;12(3):153-171. 9711873 10.1002/(SICI)1098-1004(1998)12:3&<153::AID-HUMU3&>3.0.CO;2-I
4. Rogan PK Svojanovsky S Leeder JS: Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations. Pharmacogenetics. 2003;13(4):207-218. 12668917 10.1097/01.fpc.0000054078.64000.de
5. Mucaki EJ Shirley BC Rogan PK: Prediction of mutant mRNA splice isoforms by information theory-based exon definition. Hum Mutat. 2013;34(4):557-565. 23348723 10.1002/humu.22277
6. López-Bigas N Audit B Ouzounis C: Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett. 2005;579(9):1900-1903. 15792793 10.1016/j.febslet.2005.02.047
7. Wang K Li M Hakonarson H: ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164. 20601685 10.1093/nar/gkq603 2938201
8. Churbanov A Vorechovský I Hicks C: A method of predicting changes in human gene splicing induced by genetic variants in context of cis-acting elements. BMC Bioinformatics. 2010;11(1):22. 20067640 10.1186/1471-2105-11-22 3098058
9. Pertea M Lin X Salzberg SL: GeneSplicer: A new computational method for splice site prediction. Nucleic Acids Res. 2001;29(5):1185-1190. 11222768 10.1093/nar/29.5.1185 29713
10. Shirley BC Mucaki EJ Whitehead T: Interpretation, stratification and evidence for sequence variants affecting mRNA splicing in complete human genome sequences. Genomics Proteomics Bioinformatics. 2013;11(2):77-85. 23499923 10.1016/j.gpb.2013.01.008
11. Eswaran J Cyanam D Mudvari P: Transcriptomic landscape of breast cancers through mRNA sequencing. Sci Rep. 2012;2:264. 22355776 10.1038/srep00264 3278922
12. Eswaran J Horvath A Godbole S: RNA sequencing of cancer reveals novel splicing alterations. Sci Rep. 2013;3:1689. 23604310 10.1038/srep01689 3631769
13. Kwan T Benovoy D Dias C: Genome-wide analysis of transcript isoform variation in humans. Nat Genet. 2008;40(2):225-231. 18193047 10.1038/ng.2007.57
14. Thorvaldsdóttir H Robinson JT Mesirov JP: Integrative genomics viewer (IGV): High-performance genomics data visualization and exploration. Brief Bioinform. 2013;14(2):178-192. 22517427 10.1093/bib/bbs017 3603213
15. Barnett DW Garrison EK Quinlan AR: BamTools: A C++ API and toolkit for analyzing and managing BAM files. Bioinformatics. 2011;27(12):1691-1692. 21493652 10.1093/bioinformatics/btr174 3106182
16. Yeo IK Johnson RA: A new family of power transformations to improve normality or symmetry. Biometrika. 2000;87(4):954-959. 10.1093/biomet/87.4.954
17. Johnson DH: Statistical sirens: the allure of nonparametrics. Ecology. 1995;76:1998-2000. Reference Source
18. Hubbard R: The probable consequences of violating the normality assumption in parametric statistical analysis. Area. 1978;10(5):393-398. Reference Source
19. Pruitt KD Tatusova T Maglott DR: NCBI reference sequence (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2005;33(Database Issue):D501-D504. 15608248 10.1093/nar/gki025 539979
20. Hsu F Kent JW Clawson H: The UCSC known genes. Bioinformatics. 2006;22(9):1036-1046. 16500937 10.1093/bioinformatics/btl048
21. Hubbard T Barker D Birney E: The Ensembl genome database project. Nucleic Acids Res. 2002;30(1):38-41. 11752248 10.1093/nar/30.1.38 99161
22. RDC Team R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing,2008. Reference Source
23. Fox J Weisberg S: An R Companion to Applied Regression, 2nd ed. Thousand Oaks CA: Sage,2011. Reference Source
24. Freedman D Diaconis P: On the histogram as a density estimator: L 2 theory. Zeitschrift für Wahrscheinlichkeitstheorie und Verwandte Gebiete. 1981;57(4):453-476. 10.1007/BF01025868
25. Hyndman RJ Fan Y: Sample quantiles in statistical packages. American Statistician. 1996;50(4):361-365. 10.1080/00031305.1996.10473566
26. Koboldt DC Fulton RS McLellan MD: Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70. 23000897 10.1038/nature11412 3465532
27. Larson DE Harris CC Chen K: SomaticSniper: Identification of somatic point mutations in whole genome sequencing data. Bioinformatics. 2012;28(3):311-317. 22155872 10.1093/bioinformatics/btr665 3268238
28. Saunders CT Wong WSW Swamy S: Strelka: Accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012;28(14):1811-1817. 22581179 10.1093/bioinformatics/bts271
29. Shen S Park JW Huang J: MATS: A bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data. Nucleic Acids Res. 2012;40(8):e61. 22266656 10.1093/nar/gkr1291 3333886
30. Sarkar D: Lattice: Multivariate Data Visualization with R. New York: Springer,2008. Reference Source
31. Fox J: Effect displays in R for generalised linear models. J Stat Softw. 2003;8(15):1-27. Reference Source
32. Pan Q Shai O Lee LJ: Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40(12):1413-1415. 18978789 10.1038/ng.259
33. Griffith M Griffith OL Mwenifumbo J: Alternative expression analysis by RNA sequencing. Nat Methods. 2010;7(10):843-847. 20835245 10.1038/nmeth.1503
34. Katz Y Wang ET Airoldi EM: Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods. 2010;7(12):1009-1015. 21057496 10.1038/nmeth.1528 3037023
35. Shen S Lin L Cai JJ: Widespread establishment and regulatory impact of Alu exons in human genes. Proc Natl Acad Sci U S A. 2011;108(7):2837-2842. 21282640 10.1073/pnas.1012834108 3041063
36. Kapranov P Willingham AT Gingeras TR: Genome-wide transcription and the implications for genomic organization. Nat Rev Genet. 2007;8(6):413-423. 17486121 10.1038/nrg2083
37. Singh RK Cooper TA: Pre-mRNA splicing in disease and therapeutics. Trends Mol Med. 2012;18(8):472-482. 22819011 10.1016/j.molmed.2012.06.006 3411911
38. Johnson VE: Revised standards for statistical evidence. Proc Natl Acad Sci U S A. 2013;110(48):19313-19317. 24218581 10.1073/pnas.1313476110 3845140
39. Yandell M Huff C Hu H: A probabilistic disease-gene finder for personal genomes. Genome Res. 2011;21(9):1529-1542. 21700766 10.1101/gr.123158.111 3166837
40. Feng H Qin Z Zhang X: Opportunities and methods for studying alternative splicing in cancer with RNA-Seq. Cancer Lett. 2013;340(2):179-191. 23196057 10.1016/j.canlet.2012.11.010
41. Eswaran J Horvath A Godbole S: RNA sequencing of cancer reveals novel splicing alterations. Sci Rep. 2013;3:1689. 23604310 10.1038/srep01689 3631769
42. Pal S Gupta R Davuluri RV: Alternative transcription and alternative splicing in cancer. Pharmacol Ther. 2012;136(3):283-294. 22909788 10.1016/j.pharmthera.2012.08.005
43. Takahara K Schwarze U Imamura Y: Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-a1 (V) N-propeptides and Ehlers-Danlos syndrome type I. Am J Hum Genet. 2002;71(3):451-465. 12145749 10.1086/342099 379186
44. Viner C Dorman SN Shirley BC: Input, output, and explanatory files for Veridical. figshare,2013. Data Source